IRMD PEER ANALYSIS

Iradimed Co — metric-by-metric comparison with peers and the industry median

IRMDIradimed Co

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

IRMDIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	IRMD	4DX	COH	SN	ONCSM	MEDTR	Ind. Median
P/E	54.64	—	24.11	20.83●	121.43	597.66	27.09
P/B	13.10	-77.13●	4.30	2.51	13.25	1.08	2.51
EV/EBITDA	—	—	15.11	9.98●	25.26	10.94	15.39
P/S	14.95	252.89	3.53	2.11	7.60	1.18●	2.62

Financial Health
Metric	IRMD	4DX	COH	SN	ONCSM	MEDTR	Ind. Median
Current Ratio	7.13●	6.57	2.46	2.57	2.25	3.58	3.28
Debt/Equity	—	-22.6%●	22.1%	62.9%	35.0%	1.0%	44.7%
NetDebt/EBITDA	—	0.71	0.42	1.72	0.42	-1.64●	0.82

Profitability
Metric	IRMD	4DX	COH	SN	ONCSM	MEDTR	Ind. Median
Net Margin	27.4%●	-3,684.6%	14.6%	10.1%	6.3%	0.2%	-5.7%
ROE	25.0%●	—	18.1%	12.1%	12.9%	0.2%	-8.6%
ROA	21.8%●	-264.3%	12.4%	6.1%	8.0%	0.2%	-6.4%
EBITDA Margin	37.4%●	-818.8%	24.0%	25.6%	30.6%	9.4%	5.2%

Growth + Dividend
Metric	IRMD	4DX	COH	SN	ONCSM	MEDTR	Ind. Median
Rev. Growth	14.8%	-26.0%	2.0%	—	39.1%●	6.5%	7.4%
NI Growth	19.3%●	—	-6.8%	—	—	-62.9%	16.7%
Div. Yield	0.8%	—	3.6%●	3.5%	0.0%	1.1%	1.1%
Payout	65.4%	—	81.5%	52.8%	0.0%	656.3%	39.0%

Valuation
Metric	IRMD	ENOV	INSP	QDEL	ATEC	IART	Ind. Median
P/E	54.64	—	10.96●	—	—	—	27.09
P/B	13.10	0.98	1.81	0.63●	79.15	1.29	2.51
EV/EBITDA	—	—	14.77	—	—	—	15.39
P/S	14.95	0.64	1.57	0.44●	1.84	0.82	2.62

Financial Health
Metric	IRMD	ENOV	INSP	QDEL	ATEC	IART	Ind. Median
Current Ratio	7.13●	2.04	6.34	1.43	1.90	3.38	3.28
Debt/Equity	—	95.5%	3.7%●	155.3%	3,303.4%	195.6%	44.7%
NetDebt/EBITDA	—	-1.84	-3.17	-4.98	-341.81●	-6.13	0.82

Profitability
Metric	IRMD	ENOV	INSP	QDEL	ATEC	IART	Ind. Median
Net Margin	27.4%●	-49.9%	14.3%	-45.6%	-15.9%	-30.1%	-5.7%
ROE	25.0%●	-55.5%	18.4%	-49.9%	—	-38.6%	-8.6%
ROA	21.8%●	-26.1%	16.0%	-20.0%	-15.8%	-21.8%	-6.4%
EBITDA Margin	37.4%●	-32.8%	8.8%	-20.7%	-0.2%	-17.6%	5.2%

Growth + Dividend
Metric	IRMD	ENOV	INSP	QDEL	ATEC	IART	Ind. Median
Rev. Growth	14.8%	6.0%	8.9%	-3.9%	22.5%●	1.2%	7.4%
NI Growth	19.3%	—	97.2%●	—	—	—	16.7%
Div. Yield	0.8%	—	—	—	—	—	1.1%
Payout	65.4%	—	—	—	—	—	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on IRMD

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.